Focus Partners Advisor Solutions LLC bought a new position in Globe Life Inc. (NYSE:GL - Free Report) during the 1st quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The institutional investor bought 3,047 shares of the company's stock, valued at approximately $401,000.
Several other large investors have also made changes to their positions in GL. Nuveen LLC bought a new stake in shares of Globe Life in the 1st quarter worth about $131,608,000. GAMMA Investing LLC grew its holdings in shares of Globe Life by 15,553.5% in the 1st quarter. GAMMA Investing LLC now owns 781,890 shares of the company's stock worth $102,991,000 after purchasing an additional 776,895 shares during the last quarter. Ameriprise Financial Inc. grew its holdings in shares of Globe Life by 58.6% in the 4th quarter. Ameriprise Financial Inc. now owns 917,994 shares of the company's stock worth $102,376,000 after purchasing an additional 339,162 shares during the last quarter. BNP Paribas Financial Markets bought a new stake in shares of Globe Life in the 4th quarter worth about $20,505,000. Finally, Two Sigma Advisers LP grew its holdings in Globe Life by 69.7% during the 4th quarter. Two Sigma Advisers LP now owns 393,800 shares of the company's stock worth $43,917,000 after acquiring an additional 161,700 shares during the last quarter. Institutional investors own 81.61% of the company's stock.
Analysts Set New Price Targets
A number of equities research analysts have commented on GL shares. Wall Street Zen raised shares of Globe Life from a "hold" rating to a "buy" rating in a report on Friday, May 16th. JPMorgan Chase & Co. increased their price objective on shares of Globe Life from $145.00 to $160.00 and gave the stock an "overweight" rating in a report on Tuesday, July 8th. Cfra Research raised shares of Globe Life to a "moderate buy" rating in a report on Friday, July 25th. Morgan Stanley upped their target price on shares of Globe Life from $166.00 to $171.00 and gave the company an "overweight" rating in a research report on Monday, August 18th. Finally, Wells Fargo & Company upped their target price on shares of Globe Life from $144.00 to $150.00 and gave the company an "overweight" rating in a research report on Friday, July 25th. One investment analyst has rated the stock with a Strong Buy rating, eight have issued a Buy rating and two have given a Hold rating to the stock. According to MarketBeat.com, the company has a consensus rating of "Moderate Buy" and an average price target of $152.45.
Read Our Latest Report on GL
Insiders Place Their Bets
In related news, CFO Thomas Peter Kalmbach sold 28,952 shares of the stock in a transaction that occurred on Tuesday, July 29th. The stock was sold at an average price of $140.97, for a total transaction of $4,081,363.44. Following the completion of the sale, the chief financial officer directly owned 30,665 shares of the company's stock, valued at approximately $4,322,845.05. This represents a 48.56% decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link. Also, EVP Michael Clay Majors sold 10,000 shares of the stock in a transaction that occurred on Friday, August 1st. The stock was sold at an average price of $137.41, for a total value of $1,374,100.00. Following the sale, the executive vice president directly owned 47,066 shares of the company's stock, valued at approximately $6,467,339.06. The trade was a 17.52% decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders sold a total of 84,722 shares of company stock valued at $11,733,793 in the last quarter. 1.51% of the stock is owned by company insiders.
Globe Life Stock Performance
Shares of GL stock opened at $139.73 on Friday. The company has a debt-to-equity ratio of 0.43, a current ratio of 0.06 and a quick ratio of 0.06. The stock has a market cap of $11.32 billion, a PE ratio of 11.17 and a beta of 0.56. The stock has a 50-day moving average of $132.57 and a 200-day moving average of $126.10. Globe Life Inc. has a one year low of $99.04 and a one year high of $144.00.
Globe Life (NYSE:GL - Get Free Report) last announced its quarterly earnings results on Wednesday, July 23rd. The company reported $3.27 EPS for the quarter, beating analysts' consensus estimates of $3.25 by $0.02. The company had revenue of $1.48 billion during the quarter, compared to analysts' expectations of $1.50 billion. Globe Life had a return on equity of 21.24% and a net margin of 18.11%.Globe Life's revenue was up 2.9% on a year-over-year basis. During the same period in the prior year, the business posted $2.97 EPS. Globe Life has set its FY 2025 guidance at 14.250-14.650 EPS. As a group, sell-side analysts expect that Globe Life Inc. will post 13.87 earnings per share for the current year.
Globe Life Dividend Announcement
The firm also recently announced a quarterly dividend, which will be paid on Friday, October 31st. Investors of record on Friday, October 3rd will be paid a dividend of $0.27 per share. This represents a $1.08 dividend on an annualized basis and a yield of 0.8%. The ex-dividend date of this dividend is Friday, October 3rd. Globe Life's dividend payout ratio is presently 8.63%.
Globe Life Company Profile
(
Free Report)
Globe Life Inc, through its subsidiaries, provides various life and supplemental health insurance products, and annuities to lower middle- and middle-income families in the United States. The company operates in four segments: Life Insurance, Supplemental Health Insurance, Annuities, and Investments.
See Also

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider Globe Life, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Globe Life wasn't on the list.
While Globe Life currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Enter your email address and we'll send you MarketBeat's list of seven best retirement stocks and why they should be in your portfolio.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.